Where is Shionogi based? Osaka, Japan Shionogi B.V. (known as “Shionogi Europe”) is the European headquarters of Shionogi & Co., Ltd, a leading global research-driven pharmaceutical company based in Osaka, Japan. Since 1878, we have
Where is Shionogi based?
Osaka, Japan
Shionogi B.V. (known as “Shionogi Europe”) is the European headquarters of Shionogi & Co., Ltd, a leading global research-driven pharmaceutical company based in Osaka, Japan. Since 1878, we have been striving to supply the best possible medicines to protect the health and wellbeing of the patients we serve.
How big is Shionogi?
Shionogi & Co., Ltd….Shionogi.
| Type | Public (K.K) |
|---|---|
| Products | Diagnostics Medical devices Pharmaceuticals etc. |
| Revenue | $ 3.009 billion USD (FY 2012) (¥ 282.904 billion JPY) (FY 2012) |
| Net income | $709.79 million USD (FY 2012) (¥ 66.728 billion JPY) (FY 2012) |
| Number of employees | Consolidated : 6,082 |
Who manufactures FETROJA?
Shionogi’s FETROJA® (cefiderocol) Now Available for the Treatment of Complicated Urinary Tract Infections in the U.S. | News | Shionogi Inc. – A Discovery-Based Pharmaceutical Company.
How much does cefiderocol cost?
Cefiderocol (Fetroja, Shionogi), which was approved on Nov. 14, is now available in the United States. The wholesale acquisition cost will be $1,099.98 per day.
What is Fetroja used for?
Fetroja (cefiderocol) is a cephalosporin antibacterial used to treat patients 18 years of age or older who have limited or no alternative treatment options, for the treatment of complicated urinary tract infections (cUTI), including pyelonephritis caused by susceptible Gram-negative microorganisms.
What class of drug is Cefiderocol?
Cefiderocol injection is in a class of medications called cephalosporin antibiotics. It works by killing bacteria.
When was Cefiderocol FDA approved?
Development Timeline for Fetroja
| Date | Article |
|---|---|
| Nov 14, 2019 | Approval FDA Approves Fetroja (cefiderocol) for the Treatment of Complicated Urinary Tract Infections |
| Oct 16, 2019 | U.S. FDA Advisory Committee Recommends Approval of Cefiderocol for Treatment of Complicated Urinary Tract Infections |
How much does Cefiderocol cost?
Is Cefiderocol FDA approved?
(hereafter “Shionogi”) today announces that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for FETROJA® (cefiderocol) for the treatment of patients 18 years of age or older with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP …